Quest Diagnostics - Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996

End of H1N1 'Second Wave' in Sight in the U.S., According to Quest Diagnostics

12/18/9

Quest Diagnostics Declares Quarterly Cash Dividend

12/09/9

Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition

12/03/9

Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference

11/24/9

H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics

11/20/9

Quest Diagnostics Announces Final Tender Offer Results

11/20/9

New Hair Data Validate Sharp Downward Trend in Cocaine and Methamphetamine Positivity in General U.S. Workforce, According to Quest Diagnostics Drug Testing Index(TM)

11/20/9

2009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name

11/18/9

Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes

11/17/9

Quest Diagnostics to Speak at the Lazard Capital Markets 6th Annual Healthcare Conference

11/13/9

Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering

11/12/9

Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes

11/12/9

Quest Diagnostics To Speak At The Oppenheimer 20th Annual Healthcare Conference

11/02/9

New ChartMaxx(R) V5.5 with Recovery Audit Contractor (RAC) Manager Helps Hospitals Handle RAC Audit Requests

11/02/9

New Mexico Health Information Collaborative (NMHIC) Appointed as State's Official Health Information Exchange (HIE)

10/27/9

MedPlus Maintains Top Ranking in KLAS Industry Report

10/26/9

Quest Diagnostics Health Trends (TM) Report on 2009 H1N1 Influenza

10/22/9

Quest Diagnostics Reports Strong Performance in Third Quarter 2009

10/20/9

FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics' Focus Diagnostics

10/16/9

Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health

10/07/9

Quest Diagnostics to Release Third Quarter Financial Results on October 20, 2009

10/06/9

Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs

10/05/9

Quest Diagnostics Empowers the Nation's Physicians to Immediately Embrace ePrescribing

09/23/9

U.S. Food and Drug Administration Clears Vermillion's OVA1(TM) Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass

09/11/9

Quest Diagnostics To Speak at the Bank of America Merrill Lynch Global Healthcare Conference

09/11/9

Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index

09/04/9

Focus Diagnostics Launches 2009 H1N1 Flu Test Kit to Commercial Laboratories in the U.S.

08/20/9

Quest Diagnostics Declares Quarterly Cash Dividend

08/12/9

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

07/24/9

Quest Diagnostics Reports Strong Performance in Second Quarter 2009

07/21/9

Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care

07/20/9

Quest Diagnostics To Release Second Quarter Financial Results

07/09/9

Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles'

06/24/9

Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems

06/22/9

Quest Diagnostics Announces Final Tender Offer Results

06/17/9

Quest Diagnostics to Speak at the Jefferies 3rd Annual Healthcare Conference

06/15/9

Quest Diagnostics Announces Pricing of Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes

06/12/9

New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance

06/12/9

Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C

06/08/9

Quest Diagnostics to Speak at the William Blair & Company 29th Annual Growth Stock Conference

06/08/9

Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology

06/04/9

Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program

06/03/9

Quest Diagnostics Announces Early Tender Results of Offer to Purchase Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes

06/03/9

Quest Diagnostics HemoCue AB Subsidiary to Add Avie(TM) Hemoglobin A1c to Diabetes Point-of-Care Test Suite

06/02/9

Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service

06/01/9

Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting

05/28/9

Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes

05/19/9

Quest Diagnostics to Speak at the Deutsche Bank 34th Annual Healthcare Conference

05/15/9

Quest Diagnostics to Connect to Microsoft HealthVault and Empower Patients and Physicians to Share Diagnostic Laboratory Test Results Online

05/15/9

Quest Diagnostics Declares Quarterly Cash Dividend

05/14/9

Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus

05/11/9

Quest Diagnostics Announces Annual Shareholders Meeting Webcast

05/08/9

Quest Diagnostics to Speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference

05/07/9

Cocaine Use Among U.S. Workers Declines Sharply in 2008, According to Quest Diagnostics Drug Testing Index(TM)

05/06/9

Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening

04/27/9

Quest Diagnostics Reports Strong Earnings Growth In First Quarter 2009

04/21/9

Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006

04/15/9

Quest Diagnostics to Release First Quarter Financial Results

04/13/9

MedPlus Centergy(TM) Suite for Hospitals and HIEs Paves a New, Faster Path to Healthcare Information Technology Benefits

04/03/9

Quest Diagnostics to Support Walgreens and Take Care Health Systems' Offer of Free Health Services by Providing Certain Free Laboratory Testing

03/31/9

Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State

03/17/9

Jon R. Cohen, M.D., Named Senior Vice President and Chief Medical Officer at Quest Diagnostics

03/12/9

Quest Diagnostics to Speak at Barclays Capital Global Healthcare Conference

03/09/9

Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List

03/03/9

Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis

02/20/9

Quest Diagnostics Declares Quarterly Cash Dividend

02/11/9

Quest Diagnostics Reports Growth in Revenue and Earnings for Fourth Quarter 2008 and Provides 2009 Guidance

01/26/9

Quest Diagnostics' Board Authorizes $500 Million in Share Repurchases

01/26/9

Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results

01/12/9